108 related articles for article (PubMed ID: 1498060)
1. New hormone-related markers of high risk to breast cancer.
Stoll BA; Secreto G
Ann Oncol; 1992 Jun; 3(6):435-8. PubMed ID: 1498060
[TBL] [Abstract][Full Text] [Related]
2. Western diet, early puberty, and breast cancer risk.
Stoll BA
Breast Cancer Res Treat; 1998 Jun; 49(3):187-93. PubMed ID: 9776502
[TBL] [Abstract][Full Text] [Related]
3. Does early physical maturity influence breast cancer risk?
Stoll BA; Vatten LJ; Kvinnsland S
Acta Oncol; 1994; 33(2):171-6. PubMed ID: 8204271
[TBL] [Abstract][Full Text] [Related]
4. Teenage obesity in relation to breast cancer risk.
Stoll BA
Int J Obes Relat Metab Disord; 1998 Nov; 22(11):1035-40. PubMed ID: 9822939
[TBL] [Abstract][Full Text] [Related]
5. Upper abdominal obesity, insulin resistance and breast cancer risk.
Stoll BA
Int J Obes Relat Metab Disord; 2002 Jun; 26(6):747-53. PubMed ID: 12037643
[TBL] [Abstract][Full Text] [Related]
6. Abnormal production of androgens in women with breast cancer.
Secreto G; Zumoff B
Anticancer Res; 1994; 14(5B):2113-7. PubMed ID: 7840509
[TBL] [Abstract][Full Text] [Related]
7. Timing of weight gain in relation to breast cancer risk.
Stoll BA
Ann Oncol; 1995 Mar; 6(3):245-8. PubMed ID: 7612489
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study.
Furberg AS; Jasienska G; Bjurstam N; Torjesen PA; Emaus A; Lipson SF; Ellison PT; Thune I
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):33-40. PubMed ID: 15668473
[TBL] [Abstract][Full Text] [Related]
9. Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates.
Troisi R; Lagiou P; Trichopoulos D; Xu B; Chie L; Stanczyk FZ; Potischman N; Adami HO; Hoover RN; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):224-31. PubMed ID: 18199728
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
11. Leuprolide acetate-stimulated androgen response during female puberty.
Hernandez MI; Martinez-Aguayo A; Cavada G; Avila A; Iñiguez G; Mericq V
Clin Endocrinol (Oxf); 2015 Aug; 83(2):205-11. PubMed ID: 25491105
[TBL] [Abstract][Full Text] [Related]
12. Alcohol intake and late-stage promotion of breast cancer.
Stoll BA
Eur J Cancer; 1999 Nov; 35(12):1653-8. PubMed ID: 10674009
[TBL] [Abstract][Full Text] [Related]
13. Obesity and breast cancer.
Stoll BA
Int J Obes Relat Metab Disord; 1996 May; 20(5):389-92. PubMed ID: 8696416
[TBL] [Abstract][Full Text] [Related]
14. Bringing androgens up a NOTCH in breast cancer.
Tarulli GA; Butler LM; Tilley WD; Hickey TE
Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in Japanese women with special reference to the growth hormone-insulin-like growth factor axis.
Stoll BA
Jpn J Clin Oncol; 1992 Feb; 22(1):1-5. PubMed ID: 1573784
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
17. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
18. Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women.
Key TJ
Steroids; 2011 Jul; 76(8):812-5. PubMed ID: 21477610
[TBL] [Abstract][Full Text] [Related]
19. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
20. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives.
Laudisio D; Muscogiuri G; Barrea L; Savastano S; Colao A
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():217-221. PubMed ID: 29730021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
